Tumor markers: An update

Medical Clinics of North America

Volumn 80, Issue 1, 1996, Pages 185-199

  Pamies, R J ^a   Crawford, D R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; ALPHA FETOPROTEIN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CA 50 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ANTIGEN DETECTION; BREAST CANCER; CANCER SCREENING; COLORECTAL CANCER; HUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TESTIS CANCER;

EID: 0030068933     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70435-1     Document Type: Article

References (80)

1. Albers P. G.A. Miller O. Attilio Immunohistochemical-assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ tumor at low risk for occult metastasis Cancer 75 1995 844 850
2. American Cancer Society/American Urological Society International workshop on prostate cancer and hyperplasia Cancer 70 1992 207 374
3. Ammon A. H. Eiffert S. Reil Tumor-associated antigens in effusions of malignant and benign origin Clin Invest 71 1993 434 444
4. Andersson L. What clinical information is wanted from measurements of tumor markers in carcinoma of the prostate? Scand J Clin Lab Invest 45 1985 107 114
5. Aziz K.J. P.E. Maxim The FDA's perspective on the evaluation of tumor marker tests Clin Chem 39 1993 2439 2443
6. Baker T.S. C.C. Bose H.M. Caskey-Finney Humanization of an anti-mucin antibody for breast and ovarian cancer therapy Adv Exp Med Biol 353 1994 61 82
7. Ballesta A.M. R. Molina X. Filella Carcinoembryonic antigen in staging and follow-up of patients with solid tumors Tumor Biol 16 1995 32 41
8. Bast R.C. Jr Perspectives on the future of cancer markers Clin Chem 39 1993 2444 2451
9. Bast R.C. Jr V. Hunter R.C. Knapp Pros and cons of gynecologic tumor markers Cancer 60 suppl 1984-1992
10. Benson M.C. I.S. Whang A. Pantuck Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer J Urol 147 1992 815 816
11. Birch R. S. Williams A. Cone Prognostic factors for favorable outcome in disseminated germ cell tumors J Clin Oncol 4 1986 400 407
12. Bliss P. J. Fiskin J. Poulsten An assessment of the clinical usefulness of two serum markers, ACA 15-3 and HMFG 2 in localized and metastatic breast cancer Dis Markers 11 1993 45 48
13. Bramwell M.E. V.P. Bhavanandan G. Wiseman Structure and function of the Ca antigen Br J Cancer 48 1983 127 183
14. Brawer M.K. J. Beatie M.H. Wener PSA as the initial test in prostate carcinoma screening: Results of the third year J Urol 149 suppl 1993 299A
15. Buamah P.K. A.W. Skillen A profile of serum CA 153, carcinoembryonic antigen, alkaline phosphatase, and gamma-glutamyl transferase levels in patients with breast cancer J Surg Oncol 53 1993 84 87
16. Bussemakers M.J.G. J.T. Isaacs F.M.J. Debruyne Oncogene expression in prostate cancer J Urol 9 1991 58 63
17. Byers T. R. Gorsky Estimates of costs and effects of screening for colorectal cancer in the United States Cancer 70 suppl 5 1992 1288 1295
18. Casey G. Y. Yamanake H. Friess p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis Cancer Lett 69 1993 151 160
19. Ceriani R.L. D. Larocca J.A. Peterson A novel serum assay for breast epithelial antigen using a fusion protein Anal Biochem 201 1992 178 183
20. Collins V.P. R.K. Loeffler H. Tivey Observations on growth rates of human tumors Am J Roentgenol Radium Ther Nucl Med 76 1956 988 1000
21. Devine P.L. M.A. McGuckin L.E. Ramm Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate: A blind trial with 420 patients Cancer 72 1993 2007 2015
22. Fan Q.B. M.L. Bian S.Z. Huang Amplification of the C-er-B-2(HER-2/neu) protooncogene in ovarian carcinomas Chin Med J (International Abstracts) in JAMA 273 1995
23. Filella X. R. Molina A.M. Ballesta Use of tumor markers Grau J.J. Pique J.M. Monografias clinicas en oncologia, No 8: Cancer Colorectal 1990 Doyma Barcelona 77 85
24. Ford D. Risks of cancer in BRCA 1-mutation carriers JAMA 273 1995 14101
25. Friess H. M. Buchler B. Auerbach CA 494—a new tumor marker for the diagnosis of pancreatic cancer Int J Cancer 53 1993 759 763
26. Fritsche H.A. Serum tumor markers for patient monitoring: A case-oriented approach illustrated with carcinoembryonic antigen Clin Chem 39 1993 2431 2434
27. Gerl A. C. Clemm R. Lamerz Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease Eur J Cancer 29A 1993 961 965
28. Gold P. S.O. Freedman Demonstration of tumor specific antigens in human colon carcinomas by immunological tolerance and absorption techniques J Exp Med 121 1965 439 462
29. Gullino P.M. Natural history of breast cancer: Progression from hyperplasia to neoplasia as predicted by angiogenesis Cancer 39 1977 2697 2703
30. Hare W. J.J. Tjandra I.S. Russell Comparison of mammary serum antigen assay with mammography in patients with breast cancer Med J Aust 149 1988 402 406
31. Hirayama T. Cancer incidence during a lifetime Preventive Oncology 1980 Shinjuku-Shobo Tokyo 31 36
32. Howe G.R. Pancreatic cancer Cancer Surv 19-20 1994 139 158
33. Ichikawa T. Y. Ichikawa A.L. Hawkins Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11 Cancer Res 52 1992 3486 3490
34. Ichikawa T. J.A. Schalken Y. Ichikawa H-ras expression, genetic instability, and acquisition of metastatic ability by rat prostatic cancer cells following v-H-ras oncogene transfection Prostate 18 1991 163 172
35. Iles R.K. T.E. Ind T. Chard Production of placental alkaline phosphatase (PLAP) and PLAP-like material by epithelial germ cell and non-germ cell tumours in vitro Br J Cancer 69 1994 274 278
36. Irimura T. Cancer metastasis determined by carbohydrate-mediated cell adhesion Ceriani R.L. Antigen and Antibody Engineering in Breast Cancer Diagnosis and Treatment 1994 Plenum Press New York 1 9
37. Isaacs J.T. Prostatic cancer: An overview Cancer Metastasis Rev 12 1993 1 2
38. Jeekel J. Surgery of pancreatic cancer Ann Oncol 5 suppl 3 1994 73 74
39. Jubelirer S.J. J.P. Tierney S. Oliver The value of prostatic specific antigen in prostate cancer screening in the community WV Med J 90 1994 140 142
40. Karaoglou A. A review of possible tumor markers in secondary prevention of human cancers, with special emphasis on the role of primary prevention of cancer Rec Results Cancer Res 122 1991 16 21
41. Kawa S. M. Tokoo O. Hasebe Comparative study of CA242 and Ca19-9 for the diagnosis of pancreatic cancer Br J Cancer 70 1994 481 486
42. Kelloff G.J. Progress in cancer chemoprevention: Perspectives on agent selection and short-term clinical intervention trials Cancer Res 54 suppl 1994 2015s 2024s
43. Keydar I. C.S. Chou M. Hareuveni Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens Proc Natl Acad Sci USA 86 1989 1362 1366
44. Kobayashi T. T. Kawakubo Prospective investigation of tumor markers and risk assessment in early cancer screening Cancer 73 1994 1946 1953
45. Kozwich D.L. L.C. Kramer W.P. Meilicki Application of cancer coagulant as an early detection tumor marker Cancer 74 1994 1367 1376
46. Kristal A.R. M.S. Baker A.D. Feld Evaluation of a test for abnormal rectal mucus for early detection of colon cancer Cancer Epidem Biomarkers Prev 1 1992 303
47. Lilja H. Significance of different molecular forms of serum PSA: The free, non-complexed form of PSA versus that complexed to a 1-antichymotrypsin Urol Clin North Am 20 1993 681 686
48. Lilja H. T. Bjork P. Abrahamdsson Improved separation between normals, BPH and carcinoma of the prostate by measuring free, complexed and total concentrations of prostate specific antigen J Urol 151 suppl 1994 400A
49. Littrup P.J. F. Lee C. Mettlin Prostate cancer screening: Current trends and future implications CA Cancer J Clin 42 1992 198 211
50. Long J.P. G.R. Prout The usefulness of serum acid phosphatase in monitoring patients with advanced prostate carcinoma Karr J.P. Yamanasaka H. Advances in Experimental Medicine and Biology: Prostate Cancer and Bone Metastasis 1992 Plenum Press New York 245 254
51. Matsushita Y. K.R. Cleary D.M. Ota Sialyl-dimeric LeX antigen expressed on mucin-like glycoproteins in colorectal cancer metastases Lab Invest 63 1990 780 791
52. McGrath P.C. D.T. Hollsy L.S. Hamby Proliferation-associated nucleolar antigen P-120: A prognostic marker in node-negative breast cancer Surgery 116 1994 616 621
53. Mead G.M. S.P. Stenning Prognostic factors for metastic germ call cancers treated with platinum-based chemotherapy: The International Germ Cell Cancer Collaborative Group (IGCCCG) project to standardize risk criteria (Meeting Abstract) Proc Annu Meet Am Soc Clin Oncol 13 1994 A790
54. Meden H. S. Neues S. Roben-Kampken A clinical, mammographic, sonographic, and histologic evaluation of breast cancer Int J Gynecol Obstet 48 1995 193 199
55. Murr M.M. M.G. Sarr A.J. Oishi Pancreatic cancer CA Cancer J Clin 44 1994 304 318
56. Nakamori S. M. Sameyama S. Imaoka Increased expression of sialyl Lewis X antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study Cancer Res 53 1993 3632 3637
57. Narita T. H. Funahashi Y. Satoh Serum and immunohistochemical studies of NCC-ST-439 in breast cancer J Surg Oncol 54 1993 5 8
58. Neugut A. S. Pita Rise of sigmoidoscopy in screening for colorectal cancer: A critical review Gastroenterology 95 1988 492 499
59. Nicolini A. C. Colombini L. Luciani Evaluation of serum CA 15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients Br J Cancer 64 1991 154
60. Ozylkan O. E. Baltali E. Ozylkan Ceruloplasmin level in women with breast cancer: Preliminary results Acta Oncol 31 1992 843 846
61. Pasanen P.A. M. Eskelinen K. Partanen A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score Br J Cancer 69 1994 562 565
62. Richie J.P. Detection and treatment of testicular cancer CA Cancer J Clin 43 1993 151 175
63. Rinker C.W. C.W. Schaeffer W.B. Isaacs Molecular and cellular markers for metastatic prostate cancer Cancer Metastasis Rev 12 1993 3 10
64. Roulston J.E. Novel tumour markers: A diagnostic role in pancreatic cancer? Br J Cancer 70 1994 389 390
65. Sakamoto K. M. Muratani T. Ogawa Colon cancer screening by a new test: A prospective study of asymptomatic population [abstr] Proc Am Assoc Cancer Res 32 1991 168
66. Sano C. R. Kamishiro H. Uogaeshi A new screening test for colorectal cancer detection by T antigen Jpn H Gastroenterol Surg 25 1992 1568
67. Schwartz M.K. The role of the laboratory in the prevention and detection of chronic disease Clin Chem 38 1992 1539
68. Sell S. Cancer markers of the 1990's [review] Clin Lab Med 10 1990 1 37
69. Seregni E. F. Crippa C. Botti Mucin-like carcinoma antigen (MCA) in breast cancer clinical experience at the National Institute of Milan Int J Biol Markers 8 1993 124 129
70. Shamsuddin A.M. K. Sakamoto Carbohydrate tumor marker: Basis for a simple test for colorectal cancer Jacobs M.M. Diet and Cancer: Markers, Prevention, and Treatment 1994 Plenum Press New York
71. Shapiro S. Goals of screening Cancer 70 suppl 1992 1252 1258
72. Shapiro S. W. Venet L. Straz Selection, follow-up and analysis in the Health Insurance Plan Study: A randomized trial with breast cancer screening Natl Cancer Inst Monogr 67 1985 65
73. Sugano H. Some considerations on microcancer and latent cancer Taisha Metabolism and Disease 19 suppl 1982 1193 1197
74. Toner G.C. N.L. Geller C. Tan Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in non-seminomatous germ cell tumors Cancer Res 50 1990 5904 5910
75. Trapasso J.G. de Kernion J.B. R.B. Smith The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy J Urol 152 1994 1821 1825
76. Wang J.Y. F.Z. Chen Y.Z. Yang Evaluation of non-invasive diagnostic tests in detecting cancer of the pancreas Chin Med J 103 1990 817 820
77. Wilson J. G. Junger Principles and practices of screening for colorectal cancer: A critical review Gastroenterology 95 1988 492 499
78. Yedema K.A. P. Kenemans T. Wobbes Carcinoma-assisted mucin serum markers CAM26 and CAM29: Efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium, and cervix Int J Cancer 47 1991 170 179
79. Yonezawa S. M. Osako K. Yamashita Mucin antigen expression and biological property of neoplasms of the pancreas, liver, ovary, and breast [meeting abstr] Proc Annu Am Assoc Cancer Res 35 1994 A307
80. Zdeb M.S. The probability of developing cancer Am J Epidemiol 106 1977 6 16